A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
Clinical trial NCT05569759 · COMPLETED
Trial details
- NCT number
- NCT05569759
- Sponsor
- Kezar Life Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2025-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.